Position in ICU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$38,175
+$21,757 QoQ
Shares Held
10,402
+52.1% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 18 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ICU ranks #389 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ICU
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,175 | 10,402 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $16,418 | 68,411 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,283 | 12,778 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,443 | 12,778 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,211 | 12,778 | Shares | Defined | 2025-05-13 | |
| 2024-03-31 | $110,491 | 150,533 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,626 | 12,702 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||